CyPass Clinical Experience Study
Completed
- Conditions
- Open Angle Glaucoma (OAG)
- Registration Number
- NCT01097174
- Lead Sponsor
- Transcend Medical, Inc.
- Brief Summary
This study is to evaluate the long-term safety, effectiveness and clinical experience of the CyPass Micro-Stent in patients with glaucoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 555
Inclusion Criteria
- Diagnosis of OAG
- IOP ≥ 21 mmHg and ≤ 31 mmHg (with or without ocular hypotensive medication)
Exclusion Criteria
- Acute angle closure, narrow angle, uveitic or neovascular glaucoma
- Normal tension glaucoma
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of intraoperative and postoperative adverse events Day 0 - Year 3
- Secondary Outcome Measures
Name Time Method Intraocular pressure (IOP) reduction 1 - 36 months postoperatively Ocular hypotensive medication use 1 - 36 months postoperatively
Trial Locations
- Locations (14)
University Eye Clinic
🇦🇹Salzburg, Austria
Specialized Hospital for Active Treatment of Ophthalmologic Diseases
🇧🇬Sofia, Bulgaria
Schlosspark-Klinik, Department of Ophthalmology
🇩🇪Berlin, Germany
Knappschaftskrankenhaus Bochum-Langendreer
🇩🇪Bochum, Germany
AugenKlinik Cham
🇩🇪Cham, Germany
Klinik fur Augenheilkunde, Campus Lubeck
🇩🇪Lubeck, Germany
Klinik für Augenheilkunde, Dietrich-Bonhoeffer-Klinikum
🇩🇪Neubrandenburg, Germany
Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazio
🇮🇹Catania, Italy
Wojskowy Instytut Medyczny (Military Medical Institute)
🇵🇱Warsaw, Poland
Institut Catala de Retina
🇪🇸Barcelona, Spain
Scroll for more (4 remaining)University Eye Clinic🇦🇹Salzburg, Austria